Kraig Biocraft Laboratories Announces Creation of Four New Transgenics
Kraig Labs continues to expand its inventory of revolutionary transgenics
ANN ARBOR, Mich., – May 10, 2016 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced the creation of four new lines of transgenic silkworms. These new transgenics are based on a new set of the Company’s most complex protein designs to date. These new designs are targeted for applications in performance apparel, medical, and ballistic protection, where their intended strength improvements should provide even higher levels of durability. The Company believes that these new transgenics have the potential to produce silk fibers with an unprecedented combination of physical properties with the potential to rival its existing Dragon SilkTM line. Over the next several months the Company will start testing each of these newly created transgenics to measure their performance and use for targeted application.
“These are the most complex genetic constructions that we have ever created in the Company’s history,” said COO Jon Rice. “In some cases, these designs took more than 12 months to perfect and we are just now able to confirm that this work has resulted in successful transgenics. This work represents a significant breakthrough in our efforts to bring transformative technical fibers to market and is a clear demonstration of our capability for continuous innovation.”
The Company expects to announce more details on the performance of these new materials over the coming months as performance testing is completed and each of these new transgenic silkworm lines obtain homozygosity.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
Kraig Labs Releases Q4 2015 Issue of Spider Sense
Kraig Biocraft Laboratories Announces Signing Hybrid Silk Production Agreement in Vietnam
Kraig Labs now preparing for launch of new Vietnamese subsidiary
ANN ARBOR, Mich., – February 29, 2016 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced the signing of a cooperative agreement with a governmental entity in Vietnam to develop and produce the Company’s advanced silk technologies. Under the terms of the agreement Kraig Labs has agreed to form a subsidiary company in Vietnam and to open an advanced hybrid silk research and pilot production operation.
Kraig Labs has created an efficient method of producing high strength silks using its innovative genetic engineering technologies. Demonstrating superior strength and elasticity, in some cases higher strength and elasticity than native spider silks, Kraig Labs’ Dragon SilkTM has the potential to reshape the textile industry. The research and production agreement announced today lays the groundwork for the production and further development of these advanced hybrid textiles.
“This agreement represents a major advancement for Kraig Labs and is the successful culmination of two years of negotiations and many more years of scientific research and development,” said CEO and Founder Kim Thompson. “It is a key milestone in the advancement of our longstanding business plan to bring these advanced materials to the multi-billion dollar marketplace for advanced technical textiles. It brings us a huge step closer to meeting the demand for our spider silk technologies. This agreement is important because of the tremendous existing silk and textile production infrastructure. At the same time bringing a new technology and capability to Vietnam. This agreement was the result of considerable effort by all parties involved and we are pleased to announce today the success of those efforts. I would like to personally thank our negotiation partners for their dedication in completing this first of its kind international agreement.”
The Company is currently in the process of obtaining the necessary approvals for the subsidiary and its operational plan. Over the next several months the Company plans to finalize the formation of the subsidiary, lease a research and production facility in Vietnam, hire and train local staff, obtain permits, and begin cross breeding its silkworms with local commercial silkworm lines.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
Kraig Biocraft Laboratories Announces Highlights of Conference Call
Spider Silk poised for commercialization
ANN ARBOR, Mich., – December 7, 2015 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of advanced spider silk based fibers, announced highlights from its call with Shareholders and that a recording of the call is available at www.kraiglabs.com/investors.
Highlights of the conference call included:
- The Company responded to a request from the Government and plans on providing test articles to the Government for evaluation in 2016.
- Kraig is in the process of developing materials to be evaluated for ballistics performance.
- Recently teamed with a globally recognized performance apparel manufacturer to develop applications for the Company’s silk, the first test article was produced in late November and Kraig is now scaling up that work to produce additional testing samples, as the companies work together to identify a best first product.
- Vietnamese production agreement is nearly finalized, with the full agreement drafted and going through comment process. The Company has someone in Vietnam now shepherding the agreement through.
- Vietnam’s excellent infrastructure would allow Kraig to efficiently produce quality fibers.
- The Company is actively exploring alternative production countries as a backup to Vietnam.
- Management will look to uplist to a higher exchange upon completing near term commercialization goals.
- R&D will continue, but it is no longer necessary to create a product that is ready for market. Dragon Silk’s tensile strength increased by an additional 11%, with a number of samples exceeding 2GPa, and is ready for scale and sale.
- The Company’s transgenics are showing increased generation on generation performance improvements through its selective breeding program.
- Kraig is establishing its Vietnamese subsidiary and is preparing to open an office in Ho Chi Minh City.
- Successfully produced, with Warwick Mills, the first hybrid fabric combining Monster Silk with a synthetic. The materials blended well, opening opportunities for future blended fabrics and products.
- The Company remains true to its founding objective of developing the best performing fibers, Kraig currently maintains 11 unique transgenic lines and has 7 additional lines under evaluation.
Management’s Commentary
“I think that, among other benefits, our conference call illuminates how we’ve built a solid foundation to establish production. It also explains how we plan to leverage our laboratory successes, and initial silk production, to target several end markets and channel partners. I believe our shareholders will appreciate the significant accomplishments we’ve made over the last year and we encourage all interested parties to listen to the replay broadcast of the conference call.” said Jon Rice, COO.
“With the technology foundation and strategic alignments we’ve made, we believe we are well positioned to be one of the leading players in multiple end markets, serving a multi-billion dollar industry,” stated Kim Thompson, Kraig’s founder and CEO.
Due to a technical difficulty the conference call was interrupted. The full audio, including the questions the Company was unable to address during the call, is now available at www.kraiglabs.com/investors.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com
Kraig Biocraft Laboratories to Host a Shareholder Conference Call Later Today
CEO and COO to discuss spider silk commercialization and corporate developments
ANN ARBOR, Mich., – December 4, 2015 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of advanced spider silk based fibers, announced a conference call to be hosted by Kim Thompson and Jon Rice later today, December 4, 2015 at 4:30 PM EST. The Company invites all shareholders and other interested parties to participate in the call.
Thompson, the Company’s CEO and Founder and Rice, the Company’s COO, will update shareholders on production, scientific milestones, commercialization strategy and corporate developments. Following the Company progress update, Thompson and Rice will hold a questions and answer session moderated by Ben Hansel.
Interested parties are invited to dial the toll free number below.
1-866-906-9888 and when prompted, enter access code 9285926 followed by the # (pound) sign.
It is recommended that callers dial in approximately five minutes before the conference is scheduled to begin.
The Company anticipates posting a recording of the conference call on the Company website shortly after the call for interested parties who are unable to attend the call.
Conference call: 4:30 p.m. EST (Eastern Standard Time), Today, Friday, December 4, 2015.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
Kraig Biocraft Laboratories Announces Details for Shareholder Conference Call for Friday, December 4, 2015
CEO and COO to discuss spider silk commercialization and corporate developments
ANN ARBOR, Mich., – November 30, 2015 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of advanced spider silk based fibers, announces a conference call to be hosted by Kim Thompson and Jon Rice on Friday, December 4, 2015 at 4:30 PM EST. The Company invites all shareholders and other interested parties to participate in the call.
Thompson, the Company’s CEO and Founder and Rice, the Company’s COO, will update shareholders on production, scientific milestones, commercialization strategy and corporate developments. Following the Company progress update, Thompson and Rice will hold a questions and answer session moderated by Ben Hansel. Shareholders are invited to submit question to IR@kraiglabs.com in advance of the call.
Interested parties are invited to dial the toll free number below.
1-866-906-9888 and when prompted, enter access code 9285926 followed by the # (pound) sign.
It is recommended that callers dial in approximately five minutes before the conference is scheduled to begin.
The Company anticipates posting a recording of the conference call on the Company website shortly after the call for interested parties who are unable to attend the call.
Conference call: 4:30 p.m. EST (Eastern Standard Time), Friday, December 4, 2015.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
Kraig Biocraft Laboratories Announces Shareholder Conference Call for Friday, December 4, 2015
CEO and COO to discuss spider silk commercialization and corporate developments
ANN ARBOR, Mich., – November 12, 2015 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of advanced spider silk based fibers, announces a conference call to be hosted by Kim Thompson and Jon Rice to be held on Friday, December 4, 2015 at 4:30 PM EST. The Company invites all shareholders and other interested parties to participate in the call.
Thompson, the Company’s CEO and Founder and Rice, the Company’s COO, will update shareholders on production, scientific milestones, commercialization strategy and corporate developments. Following the Company progress update, Thompson and Rice will hold a questions and answer session moderated by Ben Hansel. Shareholders are invited to submit question to IR@kraiglabs.com in advance of the call.
The conference call phone number and other details will be announced in a follow-up Company release the week of November 30, 2015.
The Company anticipates posting a recording of the conference call on the Company website shortly after the call for interested parties who are unable to attend the call.
Conference call: 4:30 p.m. EST (Eastern Standard Time), Friday, December 4, 2015.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
Kraig Labs Releases October Issue of Spider Sense
Kraig Biocraft Labs featured by Fibre2Fashion in interview with Jon Rice
Kraig Biocraft Labs featured by Fibre2Fashion in an interview with Jon Rice, discussing the emerging spider silk industry and its possible applications.
http://www.fibre2fashion.com/face2face/kraig-biocraft-laboratories/jon-rice.asp
The Company did not draft the content of this article and the link do not constitute an endorsement by the Company of such content. The Company does not control the content or information contained in this link or website. The information on such websites has not been verified by Kraig Biocraft Laboratories. The viewer should use caution and prudence when viewing such information
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
This release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC.
(720) 288-8495